ARCHIVES

Pathology Review Confirms Reserpine As Carcinogen

This article is from The Cancer Letter archive.

Vol. 06 No. 11 | March 14, 1980

Download PDF Visit The Full Archive

Related Articles

NCI Suspend Tulane, LSU From Accrual Due To Missing Data

April 29, 1994

Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center

July 25, 2013

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

New Drug Reverses Damage To Liver In Stem Cell Transplant

September 27, 2002